Clinical Trials Browser

Phase 3 × Tablets × 1 year × Clear all

NCT04055493 2025-08-26

ADAPTcycle

Phase 3 Active not recruiting

Breast Neoplasms

NCT05907057 2025-04-11

An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute